ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
4.890
-0.130 (-2.59%)
At close: Sep 18, 2026, 4:00 PM EDT
4.860
-0.030 (-0.61%)
After-hours: Sep 18, 2026, 4:10 PM EDT
ImageneBio Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, ImageneBio stock has a consensus rating of "Buy" and an average price target of $18. The average 1-year stock price forecast is 268.10% higher than the current stock price, while the lowest is $2.00 (-59.10%) and the highest is $28 (+472.60%).
Price Target: $18 (+268.10%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Aug 21, 2026.
Analyst Ratings
The average analyst rating for ImageneBio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Initiates $28 | Buy | Initiates | $28 | +472.60% | Aug 21, 2026 |
| Wedbush | Wedbush | Sell Maintains $2 | Sell | Maintains | $2 | -59.10% | Aug 6, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 5, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $30 → $24 | Buy | Maintains | $30 → $24 | +390.80% | May 8, 2026 |
Financial Forecast
Revenue This Year
n/a
from 800.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-3.31
from -9.64
EPS Next Year
-4.31
from -3.31
EPS and Forward PE are based on non-GAAP adjusted numbers.